Le Lézard
Classified in: Health
Subject: CCA

Neovasc to Host Third Quarter 2017 Conference Call


VANCOUVER, Nov. 10, 2017 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced that it will release its financial results for the third quarter 2017 on Tuesday, November 14, 2017, after markets close. The Company will subsequently hold a conference call that same day at 4:30 pm Eastern Time hosted by Mr. Alexei Marko, Chief Executive Officer, and Mr. Chris Clark, Chief Financial Officer. A question and answer session will follow the corporate update.

Conference Call Details


Tuesday, November 14, 2017


4:30 pm ET


888 390 0605 or 416 764 8609


A link to the live audio webcast of the conference call will also be available on the Presentations and Events page of the Investors section of Neovasc's website at www.neovasc.com. Please connect at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to hear the webcast.  

A recording of the call will be available for 72 hours by calling 888 390 0541 or 416 764 8677 and using passcode 762334#.

About Neovasc Inc. 
Neovasc is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace.  Its products include the Neovasc Reducertm, for the treatment of refractory angina which is not currently available in the United States and has been available in Europe since 2015 and the Tiaratm, for the transcatheter treatment of mitral valve disease, which is currently under investigation in the United States, Canada and Europe. The Company also sells a line of advanced biological tissue products that are used as key components in third-party medical products including transcatheter heart valves. For more information, visit: www.neovasc.com.

SOURCE Neovasc Inc.

These press releases may also interest you

at 17:30
GemCare Wellness, a national health coaching and disease management company, awarded Kerry Fairchild the first Susan Raber-Satterfield, Coach of the Year Award. The award was named after the late Susan Raber-Satterfield who played a key role in the...

at 17:30
Diplomat Pharmacy, Inc. plans to combat rising healthcare costs throughout 2018 by advancing generic drugs, biosimilars, and affordable brand medications. Joel Saban, president of Diplomat, said the growing market for...

at 17:00
Bayer and Loxo Oncology, Inc., today announced the publication in The New England Journal of Medicine (NEJM) of larotrectinib data for pediatric and adult patients whose tumors harbor Neurotrophic Tyrosine Receptor Kinase (NTRK) gene fusions. These...

at 16:47
Asm. Autumn Burke (D-Inglewood) introduced legislation today, AB 2741, that aims to stop the abuse of prescription opioids in minors.   This legislation addresses the opioid epidemic by tightening prescription regulations. "As a legislator and a...

at 16:33
Solis Tek Inc. , a vertically integrated technology innovator, developer, manufacturer and distributor focused on bringing products and solutions to commercial cannabis growers in legal markets across the U.S, today announced the appointment of...

at 16:33
It is estimated 500,000 of this generation of wounded veterans live with the symptoms of post-traumatic stress disorder (PTSD). Another 320,000 suffered a traumatic brain injury (TBI). There are few proven methods to diagnose and treat the signature...

News published on 10 november 2017 at 14:56 and distributed by: